181 related articles for article (PubMed ID: 24225742)
1. The predictive ability of a CK5/p63/CK8/18 antibody cocktail in stratifying breast papillary lesions on needle biopsy: an algorithmic approach works best.
Reisenbichler ES; Adams AL; Hameed O
Am J Clin Pathol; 2013 Dec; 140(6):767-79. PubMed ID: 24225742
[TBL] [Abstract][Full Text] [Related]
2. Luminal cytokeratin expression profiles of breast papillomas and papillary carcinomas and the utility of a cytokeratin 5/p63/cytokeratin 8/18 antibody cocktail in their distinction.
Reisenbichler ES; Balmer NN; Adams AL; Pfeifer JD; Hameed O
Mod Pathol; 2011 Feb; 24(2):185-93. PubMed ID: 21076459
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 5 and estrogen receptor immunohistochemistry as a useful adjunct in identifying atypical papillary lesions on breast needle core biopsy.
Grin A; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2009 Nov; 33(11):1615-23. PubMed ID: 19675450
[TBL] [Abstract][Full Text] [Related]
4. The clinical use of a P63/cytokeratin7/18/cytokeratin5/14 antibody cocktail in diagnostic breast pathology.
Reisenbichler ES; Ross JR; Hameed O
Ann Diagn Pathol; 2014 Dec; 18(6):313-8. PubMed ID: 25224390
[TBL] [Abstract][Full Text] [Related]
5. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of immunocytochemistry using a Breast Marker antibody cocktail targeting P63/cytokeratin7/18/cytokeratin5/14 for fine needle aspiration of the breast: a retrospective cohort study of 139 cases.
Tanaka S; Kanomata N; Teramura K; Wakita K; Kunihisa T; Yano Y; Moriya T; Hayashi Y
Cytopathology; 2016 Dec; 27(6):465-471. PubMed ID: 27060708
[TBL] [Abstract][Full Text] [Related]
7. An analysis of cyclin D1, cytokeratin 5/6 and cytokeratin 8/18 expression in breast papillomas and papillary carcinomas.
Wang Y; Zhu JF; Liu YY; Han GP
Diagn Pathol; 2013 Jan; 8():8. PubMed ID: 23327593
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
[TBL] [Abstract][Full Text] [Related]
9. Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification.
Yamauchi K; Fujioka Y; Kogashiwa Y; Kohno N
J Clin Pathol; 2011 Oct; 64(10):875-9. PubMed ID: 21705376
[TBL] [Abstract][Full Text] [Related]
10. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision.
Chang JM; Han W; Moon WK; Cho N; Noh DY; Park IA; Jung EJ
Ann Surg Oncol; 2011 Sep; 18(9):2506-14. PubMed ID: 21369740
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry increases the accuracy of diagnosis of benign papillary lesions in breast core needle biopsy specimens.
Shah VI; Flowers CI; Douglas-Jones AG; Dallimore NS; Rashid M
Histopathology; 2006 May; 48(6):683-91. PubMed ID: 16681684
[TBL] [Abstract][Full Text] [Related]
12. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
[TBL] [Abstract][Full Text] [Related]
13. Use of p63 and CD10 in the differential diagnosis of papillary neoplasms of the breast.
de Moraes Schenka NG; Schenka AA; de Souza Queiroz L; de Almeida Matsura M; Vassallo J; Alvarenga M
Breast J; 2008; 14(1):68-75. PubMed ID: 18086274
[TBL] [Abstract][Full Text] [Related]
14. Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63.
Douglas-Jones A; Shah V; Morgan J; Dallimore N; Rashid M
Histopathology; 2005 Aug; 47(2):202-8. PubMed ID: 16045782
[TBL] [Abstract][Full Text] [Related]
15. Mammary lesions diagnosed as "papillary" by aspiration biopsy: 70 cases with follow-up.
Simsir A; Waisman J; Thorner K; Cangiarella J
Cancer; 2003 Jun; 99(3):156-65. PubMed ID: 12811856
[TBL] [Abstract][Full Text] [Related]
16. The significance of combined CK5/6 and p63 immunohistochemistry in predicting the risks of subsequent carcinoma development in intraductal papilloma of the breast.
Yang Y; Suzuki K; Abe E; Li C; Uno M; Akiyama F; Yamauchi H; Kikuchi M; Ohde S; Deshpande G; Shibahara Y; Nakamura Y; Sasano H
Pathol Int; 2015 Feb; 65(2):81-8. PubMed ID: 25572436
[TBL] [Abstract][Full Text] [Related]
17. Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?
Koo JS; Han K; Kim MJ; Moon HJ; Kim EK; Park BW
Breast Cancer Res Treat; 2013 Feb; 137(3):797-806. PubMed ID: 23292118
[TBL] [Abstract][Full Text] [Related]
18. Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note.
Yamaguchi R; Tanaka M; Tse GM; Yamaguchi M; Terasaki H; Nomura Y; Takenaka M; Naito Y; Akiba J; Yano H
J Clin Pathol; 2014 Mar; 67(3):258-62. PubMed ID: 24062357
[TBL] [Abstract][Full Text] [Related]
19. Imaging-guided core needle biopsy of papillary lesions of the breast.
Rosen EL; Bentley RC; Baker JA; Soo MS
AJR Am J Roentgenol; 2002 Nov; 179(5):1185-92. PubMed ID: 12388496
[TBL] [Abstract][Full Text] [Related]
20. The value of p63 and CK5/6 expression in the differential diagnosis of ductal lesions of breast.
Ding Y; Ruan Q
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):405-7. PubMed ID: 17120733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
